Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10


Stebel, A; Brachetti, C; Kunkel, M et al.

Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1

ONCOLOGY REPORTS. Bd. 21. H. 1. 2009 S. 217-222


Oesch-Bartlomowicz, B; Oesch, F

Role of cAMP in mediating AHR signaling

Biochem Pharmacol. Bd. 77. H. 4. 2009 S. 627-41


Fritz, G; Issinger, OG; Olsen, BB

Selectivity analysis of protein kinase CK2 inhibitors DMAT, TBB and resorufin in cisplatin-induced stress responses

INTERNATIONAL JOURNAL OF ONCOLOGY. Bd. 35. H. 5. 2009 S. 1151-1157


Fritz, G

Targeting the mevalonate pathway for improved anticancer therapy.

Curr Cancer Drug Targets. Bd. 9. H. 5. 2009 S. 626-38


Naumann, SC; Roos, WP; Jost, E et al.

Temozolomide cells: response related to MGMT, MMR, DSBs, and p53

Br J Cancer. Bd. 100. H. 2. 2009 S. 322-33


Roos, WP; Tsaalbi-Shtylik, A; Tsaryk, R et al.

The translesion polymerase Rev3L in the tolerance of alkylating anticancer drugs

Mol Pharmacol. Bd. 76. H. 4. 2009 S. 927-34




Li, PC; Lam, E; Roos, WP et al.

Artesunate derived from traditional Chinese medicine induces DNA damage and repair

Cancer Res. Bd. 68. H. 11. 2008 S. 4347-51